A New Acupuncture Study for Asthma
Although asthma symptoms can be temporarily controlled, it
is recommended to use effective low-risk, non-drug strategies to constitute a
significant advance in asthma management. Acupuncture has been traditionally
used to treat asthma; however, the evidence for the efficacy of this treatment
is still lacking. Previous clinical trials of acupuncture in treating asthma
were limited by methodological defects; therefore, high-quality research is
required. This trial is designed as a multi-center, randomized, double-blind,
parallel-group controlled trial. Patients with mild to moderate asthma will be
randomly allocated to either a verum acupuncture plus as-needed salbutamol
aerosol and/or prednisone tablets group or a sham acupuncture plus as-needed
salbutamol aerosol and/or prednisone tablets group. Acupoints used in the verum
acupuncture group are GV14 (Da Zhui), BL12 (Feng Men), BL13 (Fei Shu) and
acupoints used in the sham acupuncture group are DU08 (Jin Suo), BL18 (Gan
Shu), BL19 (Dan Shu). After a baseline period of 1 week, the patients in both
groups will receive verum/sham acupuncture once every other day with a total of
20 treatment sessions in 6 weeks and a 3-month follow-up. The primary outcome
will be measured by using the asthma control test and the secondary outcomes
will be measured by using the percentage of symptom-free days, the average
dosage of salbutamol aerosol and/or prednisone tablets, lung functions, daily
asthma symptom scores, asthma quality of life questionnaire, and so on. This
trial will assess the effect of acupuncture on asthma and aims to provide
reliable clinical evidence for the efficacy of acupuncture in treating asthma.
No comments:
Post a Comment